ID

42533

Descrição

Study ID: 105874 Clinical Study ID: 105874 Study Title: Bridging Safety & Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine RTS,S/AS01E (0.5 mL Dose) to RTS,S/AS02D (0.5 mL Dose) Administered IM According to a 0, 1, 2-Month Schedule in Gabonese Children Aged 18 Months to 4 Years Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00307021 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049 Trade Name: N/A Study Indication: Malaria ODM derived from https://clinicaltrials.gov/ct2/show/NCT00307021. A Phase II randomized, double-blind bridging study of the safety and immunogenicity of GlaxoSmithKline Plasmodium falciparum malaria vaccine RTS,S/AS01E (0.5 mL dose) to RTS,S/AS02D (0.5 mL dose) administered IM according to a 0, 1, 2- month vaccination schedule in children aged 18 months to 4 years living in Gabon. Clinical Visits: This study has a total of 7 visits. Visit 1 = Screening, Visits 2-6 are during the double-blind phase (Month 0-3) and Visit 7 is during the single-blind phase (Month 4-14). Vaccine administration takes place during visits 2, 4, and 5 (Visit 2 = Dose 1; Visit 4 = Dose 2; Visit 5 = Dose 3). Field-worker Visits: During the double-blind phase, clinical visits are accompanied by daily field-worker visits subsequent to each vaccine administration visit. Additional field-worker visits also take place during months 4 to 13 of the single-blind phase. Randomisation / Treatment Allocation takes place at visit 2 prior to the first vaccination. The subsequent record treatment number should documented at visit 2. Information on the subject's demographics, body weight, and HBV immunization status (incl. vaccination dates) should also be recorded at clinical visit 2. Please note that informed consent has to be obtained prior to any study procedure.

Link

https://clinicaltrials.gov/ct2/show/NCT00307021

Palavras-chave

Versões (1)
  1. 24/08/2021 24/08/2021 -
Titular dos direitos

GlaxoSmithKline

Transferido a

24 de agosto de 2021

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Safety & Immunogenicity of two GSK Biologicals' Candidate Malaria Vaccines in young children, NCT00307021

Inglês

Demographics, Randomisation, Weight, and HBV Immunization Status

1 Formulários  
Administrative Documentation
Descrição

Administrative Documentation

Alias
UMLS CUI-1
C1320722
Subject number
Descrição

Subject number

Tipo de dados

integer

Alias
UMLS CUI [1]
C2348585
Date of visit
Descrição

Date of visit

Tipo de dados

date

Alias
UMLS CUI [1]
C1320303
Demographics
Descrição

Demographics

Alias
UMLS CUI-1
C0011298
Date of birth
Descrição

Date of birth

Tipo de dados

date

Alias
UMLS CUI [1]
C0421451
Gender
Descrição

Gender

Tipo de dados

text

Alias
UMLS CUI [1]
C0079399
Randomisation / Treatment allocation
Descrição

Randomisation / Treatment allocation

Alias
UMLS CUI-1
C0034656
UMLS CUI-2
C1522541
Record treatment number
Descrição

Treatment number

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C1522541
UMLS CUI [1,2]
C0600091
Body weight
Descrição

Body weight

Alias
UMLS CUI-1
C0005910
Body weight
Descrição

Body weight

Tipo de dados

float

Unidades de medida
  • kg
Alias
UMLS CUI [1]
C0005910
kg
HBV immunization status
Descrição

HBV immunization status

Alias
UMLS CUI-1
C0552506
UMLS CUI-2
C0019163
Was Hepatitis B vaccine administered?
Descrição

If Yes, please provide the dates of the first, second, and third vaccination in the items below.

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2240392
UMLS CUI [1,2]
C2368628
If Yes, date of 1st vaccination
Descrição

Date in time hepatitis B vaccine administration (1st)

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2240392
UMLS CUI [1,3]
C2368628
UMLS CUI [1,4]
C0205435
If Yes, date of 2nd vaccination
Descrição

Date in time hepatitis B vaccine administration (2nd)

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2240392
UMLS CUI [1,3]
C2368628
UMLS CUI [1,4]
C0205436
If Yes, date of 3rd vaccination
Descrição

Date in time hepatitis B vaccine administration (3rd)

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2240392
UMLS CUI [1,3]
C2368628
UMLS CUI [1,4]
C0205437
Voltar ao início da página

Similar models

Demographics, Randomisation, Weight, and HBV Immunization Status

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Administrative Documentation
C1320722 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Date of visit
Item
Date of visit
date
C1320303 (UMLS CUI [1])
Item Group
Demographics
C0011298 (UMLS CUI-1)
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Gender
text
C0079399 (UMLS CUI [1])
Gender
Code List
Gender
CL Item
Male (M)
CL Item
Female (F)
Item Group
Randomisation / Treatment allocation
C0034656 (UMLS CUI-1)
C1522541 (UMLS CUI-2)
Treatment number
Item
Record treatment number
integer
C1522541 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
Body weight
C0005910 (UMLS CUI-1)
Body weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Item Group
HBV immunization status
C0552506 (UMLS CUI-1)
C0019163 (UMLS CUI-2)
Hepatitis B vaccine administered
Item
Was Hepatitis B vaccine administered?
boolean
C2240392 (UMLS CUI [1,1])
C2368628 (UMLS CUI [1,2])
Date in time hepatitis B vaccine administration (1st)
Item
If Yes, date of 1st vaccination
date
C0011008 (UMLS CUI [1,1])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,4])
Date in time hepatitis B vaccine administration (2nd)
Item
If Yes, date of 2nd vaccination
date
C0011008 (UMLS CUI [1,1])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
Date in time hepatitis B vaccine administration (3rd)
Item
If Yes, date of 3rd vaccination
date
C0011008 (UMLS CUI [1,1])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205437 (UMLS CUI [1,4])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial